"Designing Growth Strategies is in our DNA"

Transplantation Market Size, Share & COVID-19 Impact Analysis, By Product Type (Tissue Products, Immunosuppressive Drugs, and Preservation Solutions), By Application (Organ Transplant, and Tissue Transplant), By End User (Hospitals, Transplantation Centers, and Others), and Regional Forecast, 2021-2028

Region : Global | Format: PDF | Report ID: FBI105049

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version

The global transplantation market size was USD 5.47 billion in 2020. The global impact of COVID-19 has been unprecedented and staggering, with transplants witnessing a negative demand shock across all regions amid the pandemic. Based on our analysis, the global market exhibited a huge decline of -52.5% in 2020 as compared to the average year-on-year growth during 2017-2019. The market is projected to grow from USD 7.24 billion in 2021 to USD 14.67 billion in 2028, growing at a CAGR of 10.6% in the 2021-2028 period. The sudden rise in the growth rate is attributable to this market’s demand and growth, returning to pre-pandemic levels once the pandemic is over.


Over the past years, there has been increasing awareness regarding organ donation and registration. The widespread popularity of organ registration is projected to influence the market dynamics positively. Coupled with this, the rising prevalence of chronic diseases is further estimated to surge market growth in the coming years. In addition, support from government organizations has primarily helped the acceptance of organ donor registration. However, there is still a huge gap between organ donors and organ recipients' demand and supply. However, the technological advancements in organ transplant surgeries are projected to reduce this supply-demand gap slowly.


The Outbreak of COVID-19 Pandemic to Reduce Demand for Transplant Surgeries Worldwide


The sudden outbreak of coronavirus at the beginning of 2019 has left the global healthcare system in a huge dilemma. The overwhelming coronavirus patient admission in public and private hospitals has compelled governing bodies to delay elective and non-urgent surgeries in hospitals and ambulatory care centers. This has widely impacted this market globally. The pandemic has also led to a lower number of registers for organ transplant surgeries worldwide. The COVID-19 infection has also led to large rejections of organs from transplant donors. In May 2020, the Italian National Authority for Transplantation released a document guiding that all donor patients must be tested negative for SARS-CoV-2, and potential positive donor organs have to be discarded.


LATEST TRENDS


Request a Free sample to learn more about this report.


Active Initiatives by Government and Non-Government Organizations to Increase Donor Lists


There is a massive gap in the demand and supply of organ transplant recipients and donors. This gap has led to an increase in NGOs’ and government bodies' involvement to increase awareness regarding registering for organ donation. Additionally, campaigns endorsed by celebrities have also gained traction among NGOs to increase donor registers across the globe. For instance, organ donation pledges in India grew by an astounding 16,500% in 2018 owing to endorsements and organ donation pledges by popular Bollywood actors such as Aamir Khan and Priyanka Chopra.


DRIVING FACTORS


Increasing Prevalence of Chronic Diseases to Propel Growth


Growing prevalence and incidence of chronic diseases such as cancer, kidney failure, COPD, and lupus frequently lead to catastrophic damage to tissue and organs. According to the American Lung Association, over 9 million adults over 18 suffered from chronic bronchitis in the U.S in the year 2018. Additionally, the organization also states that in 2018 over 200,000 new lung cancer cases were recorded in the U.S.


An upsurge in organ failure has resulted in a growth in demand for transplant procedures. According to the American Journal of Lung Transplantation, the number of lung transplant surgeries in the U.S reached a record high of more than 200 in the year 2017. There was a growth of 133 lung transplants from the previous year. Consecutively, all these factors are estimated to augment the transplantation market growth in the upcoming years.


Technological Advancements in Transplant Surgeries to Boost Market Potential


According to the U.S Government's information on organ donation and transplantation, there are currently more than 107,000 men, women, and children on the national transplant waiting list as of February 2021. The increasing burden of the patient number, demanding an organ/tissue transplant, is compelling researchers worldwide to bring alternatives for organ replacement surgeries.


A new 3D printing technology focused on printing an organ/tissue precisely like the one inside the body has emerged in the transplantation industry, which is anticipated to revolutionize the market. For instance, a bioprinting company REGEMAT 3D has more than 60 active projects worldwide, and the company has its presence in over 20 countries around the globe. It has also continued its expansion in Colombia by setting up its new headquarters. Therefore, medical devices' technological advancements are anticipated to provide substantial growth opportunities for the market during the forecast period.


RESTRAINING FACTORS


Shortage of Organs for the Treatment of Organ Failure to Restrict Market Growth


Globally, the scarcity of organs is the main problem. Organ donors are relatively less as compared to patients waiting for organ transplant surgery. For Instance, according to the United Network for Organ Sharing (UNOS), in 2019, in the U.S., around 115,000 people are waiting for organ transplants. Thus, the dearth of donors means 20 persons decrease each day in the U.S. while waiting for a life-saving organ transplant. There is a massive gap in the demand and supply of organs for transplant surgery. Consecutively, all the above factors are likely to hamper the market growth.


SEGMENTATION


By Product Type Analysis


To know how our report can help streamline your business, Speak to Analyst


Tissue Segment to Dominate Backed by Advent of Unique Products


Based on the segmentation of the market by product type, the division includes tissue products, immunosuppressive drugs, and preservation solutions. The tissue segment held the majority of the transplantation market share in 2020. Factors such as the advent of new, improved products offer enhanced treatment. Such products include Chondrofix Osteochondral Allograft, DeNovo NT Graft, and DuraMatrix Collagen Dura Substitute Membrane. Hence, the accessibility of such progressive products and techniques is anticipated to spur market growth.


On the other hand, the immunosuppressive drugs segment is expected to emerge as the fastest-growing segment during the projected period owing to the growing adoption of these drugs to prevent post-transplant organ or tissue rejection. Besides, the preservation solutions segment is anticipated to show substantial growth. Several government initiatives to fund stem cell research and several awareness programs are attributed to the segment's development. Moreover, an upsurge in organ failure cases and growing demand for transplant procedures are likely to aid the market growth.


By Application Analysis


Tissue Transplant Segment to Lead Fueled by Rising Number of Road Accidents


Based on application, the market is segmented into organ transplant and tissue transplant. The tissue transplant segment holds a dominant share in the market during the projected time frame. The dominance is due to the conductance of a large number of tissue replacements. In addition, the rise in the number of road accidents coupled with burn cases is likely to boost the demand for tissue products. For Example, Gemeinnützige Gesellschaft Gmbh, a non-profit organization, has carried out over 5,500 tissue transplants in Germany in the year 2018.


On the flip side, the organ transplant segment is estimated to witness a significant CAGR from 2021-2028. Factors such as the growing usage of immunosuppressive drugs and a rise in organ transplant procedures are anticipated for the segment's growth. For Instance, according to the Mayo Clinic, around 8,000 liver transplant surgeries were carried out in the U.S in the year 2017.


By End User Analysis


Surging Number of Transplant Procedures to Assist Growth of Hospitals Segment


In terms of the end-user, the market is segmented into hospitals, transplantation centers, and others. The hospital segment holds the lion’s share globally due to a larger number of transplants in these facilities. In addition, factors such as the availability of well-established databases for organ obtainability in most hospitals are likely to boost the market growth. Besides, the transplantation centers are expected to grow and witness the highest CAGR during the forecast period. Factors attributed to their growth include growing demand for transplantation procedures in advanced healthcare centers with innovative techniques.


Moreover, the government's initiatives to boost organ donation are estimated to drive the segment's growth. For Instance, the NHS carries out regular public awareness drives in the U.K to educate people on registering for organ donation. In 2019, the NHS Blood and Transplant unit launched a yearlong awareness campaign to increase organ donor registers.


The other segment is expected to witness moderate growth over the forecast period due to the lesser availability of well-developed infrastructure in emerging countries and other developing countries.


REGIONAL INSIGHTS


North America Transplantation Market Size, 2020 (USD Billion)

To get more information on the regional analysis of this market, Request a Free sample


The market size in North America stood at USD 2.29 billion in 2020. The dominance of this region is attributable to a well-developed healthcare infrastructure coupled with leading players in the region. Another major factor attributed to the region's growth is the launch of novel products in the region. In November 2020, Lupin launched Tacrolimus immunosuppressive drug in partnership with Concord Biotech in the U.S. Europe holds the second-largest market position due to its investments in R&D for the activities. This, together with the large patient population in the region, is likely to drive growth during the forecast period.


Moreover, Asia Pacific is projected to witness the highest CAGR due to the growing number of chronic diseases and the region's rising geriatric populace. According to the World Bank, Besides, Latin America, the Middle East, and Africa are likely to witness moderately slower growth due to the lesser adoption of high-cost transplants in most under-developed countries.


To know how our report can help streamline your business, Speak to Analyst


KEY INDUSTRY PLAYERS


Significant R&D Investments by Key Players to Improve Business Outcome


The market is highly fragmented due to key players' presence varying from start-ups to well-established ones. The key players driving the market are focused on developing novel products to attain effective transplant procedures. Moreover, partnerships, mergers, and acquisitions support merchants in growing their current product portfolio and geographical reach. For instance, in September 2020, CollPlant Biotechnologies announced the collaboration expansion of United Therapeutics Corporation.


LIST OF KEY COMPANIES PROFILED:



  • Novartis International AG (Basel, Switzerland)

  • AbbVie Inc. (Illinois, U.S)

  • Arthrex, Inc. (Florida, U.S)

  • Biolife Solutions (Washington, U.S)

  • Teva Pharmaceutical (Petah Tikva, Israel)

  • Veloxis Pharmaceuticals, Inc. (Denmark)

  • CareDx. (California, U.S)

  • TransMedics, Inc. (Andover, MA)

  • Other Players


KEY INDUSTRY DEVELOPMENTS:



  • February 2021 – CareDx announced its acquisition of TX Services, LLC, to expand into the Pre-Transplant Kidney Space.

  • June 2019 – Eurofins Scientific announced its acquisition of Transplant Genomics Inc. to expand the company’s capabilities and testing footprints.


REPORT COVERAGE


An Infographic Representation of Transplantation Market

To get information on various segments, share your queries with us



The global market research report provides a detailed analysis of the market. It focuses on key aspects such as leading companies, product types, product applications, and end-users. Besides this, the report offers insights into the market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the developed market in recent years.


Report Scope & Segmentation


















































 ATTRIBUTE



  DETAILS



Study Period



  2017-2028



Base Year



  2020



Forecast Period



  2021-2028



Historical Period



  2017-2019



Unit



  Value (USD Billion)



Segmentation



   Product Type; Application; End User; and Region



By Product Type


 




  • Tissue Products

  • Immunosuppressive Drugs

  • Preservation Solutions



By Application


 




  • Organ Transplant

  • Tissue Transplant



By End-User


 




  • Hospitals

  • Transplantation Centers

  • Others



By Geography


 




  • North America

    • By Product Type

    • By Application

    • By End-User

    • By Country

      • USA (By Application)

      • Canada (By Application)





  • Europe

    • By Product Type

    • By Application

    • By End-User

    • By Country

      • UK (By Application)

      • Germany (By Application)

      • France (By Application)

      • Italy (By Application)

      • Spain (By Application)

      • Scandinavia (By Application)

      • Rest of Europe (By Application)





  • Asia Pacific

    • By Product Type

    • By Application

    • By End-User

    • By Country

      • Japan (By Application)

      • China (By Application)

      • India (By Application)

      • Australia (By Application)

      • Southeast Asia (By Application)

      • Rest of Asia Pacific (By Application)





  • Latin America

    • By Product Type

    • By Application

    • By End-User

    • By Country

      • Brazil (By Application)

      • Mexico (By Application)

      • Rest of Latin America (By Application)





  • Middle East & Africa

    • By Product Type

    • By Application

    • By End-User

    • By Country

      • GCC (By Application)

      • South Africa (By Application)

      • Rest of MEA (By Application)







Frequently Asked Questions

Fortune Business Insights says that the global market size was USD 5.47 billion in 2020 and is projected to reach USD 14.67 billion by 2028.

In 2020, the North American market size stood at USD 2.29 billion.

Registering a CAGR of 10.6%, the market will exhibit strong growth in the forecast period (2021-2028).

The tissue products segment is expected to lead the market during the forecast period.

The growing number of transplantation procedures globally and the introduction of advanced products by renowned players are major factors driving the market's growth.

TransMedics Inc., Care Dx, and AbbVie Inc. are the major players in the global market.

North America dominated the market in terms of share in 2020.

The increased demand for technologically advanced products is expected to drive the adoption of transplant surgeries.

Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts

Speak to an Expert
Transplantation Market Size, Share and Global Industry Trend Forecast till 2026
  • Mar, 2021
  • 2020
  • 2017-2019
  • 120

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Galemed
Grifols
3M
Ipsos
Roche

Related Reports

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X